Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.
about
Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxinA live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniaeOral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice.Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase.Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strainsSalmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccineComparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.Construction, characterization, and immunogenicity of an attenuated Salmonella enterica serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoterProgress towards development of a vaccine for amebiasis.Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in ratsA recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscessStudies of immunity and bacterial invasiveness in mice given a recombinant salmonella vector encoding murine interleukin-6.Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strainImmunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar TyphimuriumSafety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.Salmonella enterica serovar Typhi live vector vaccines finally come of ageImproved delivery of the OVA-CD4 peptide to T helper cells by polymeric surface display on Salmonella.A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.
P2860
Q33748369-5F035586-C920-4629-B76C-2BC53F59B946Q33757861-C831628D-DD0D-458A-8E42-F414019FFE29Q33767936-B59DB84C-75A4-4B88-9450-B788E8AF0BC7Q33877406-66351459-DF50-46CE-B399-0A73F1EE9C80Q33970555-0594938B-4CB0-4F66-97D5-D43224A4C8EBQ34004151-A2BE8CC5-605B-448A-B0D8-1ACAE5A11A30Q34004556-8F391230-0FF7-47CD-B524-D5532F2376AAQ34119481-99DEFADC-39E0-4A84-8A50-8A7C469B32BCQ34120949-8475FBD6-9254-4BD1-A8A0-290078DBB1BAQ34529634-7FAEA7B4-2411-4AB3-BC75-ABCA4399A9DBQ35164780-E283F187-A2BD-45D1-9663-E3985A9350BDQ35375735-63E21245-FE53-40A6-AEE1-C675E204F109Q35413101-DD1AAFA6-AE18-4B19-980A-3FB22ECDBB79Q35434055-264B46AE-DF0F-4D8D-A3E6-5EF11A47D108Q35486883-19252F7F-24B3-4B83-9F01-C42D0CBB25BDQ35505997-1DC911BC-41EE-410D-AA4E-59687DAC9D23Q35532132-03C59A58-4C26-49A1-910A-3463C7D288D3Q35550509-F049BE15-F43A-4583-B48E-CFFA2F9404DFQ35553394-E87C9C19-BDB7-4780-A8B8-9A1AAAFFA4B0Q37106127-424FD1AF-651C-46E8-B92C-12E57D757817Q40633254-899D68A6-D37D-4873-81D1-ECDBEF6BCD56Q42657781-33A9E980-7C7D-44CE-92A0-217B501C8C15
P2860
Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Hybrid hepatitis B virus core- ...... la typhi for oral vaccination.
@ast
Hybrid hepatitis B virus core- ...... la typhi for oral vaccination.
@en
type
label
Hybrid hepatitis B virus core- ...... la typhi for oral vaccination.
@ast
Hybrid hepatitis B virus core- ...... la typhi for oral vaccination.
@en
prefLabel
Hybrid hepatitis B virus core- ...... la typhi for oral vaccination.
@ast
Hybrid hepatitis B virus core- ...... la typhi for oral vaccination.
@en
P2093
P2860
P1476
Hybrid hepatitis B virus core- ...... lla typhi for oral vaccination
@en
P2093
D L Peterson
D R Milich
P2860
P304
P407
P577
1994-05-01T00:00:00Z